Results 211 to 220 of about 12,288 (265)

Survival after primary and booster COVID-19 vaccination in patients with COPD. [PDF]

Clin Exp Vaccine Res
Karabulut SS, Nemli A, Koçyiğit Y.
europepmc   +1 more source

Efficacy and Safety of mRNA-Based COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis. [PDF]

Vaccines (Basel)
Alkhidir M, Sridharan K.
europepmc   +1 more source

Unraveling COVID-19-vaccination-induced bullous pemphigoid: a case report and review of the literature. [PDF]

J Med Case Rep
Chandrasekaran S, Kamboj M, Baddepudi S, Raj R, Suresh C, Sanker V, Dave T, Wijenaike N.   +7 more
europepmc   +1 more source

The Older Population’s Antibody Response to SARS-CoV-2 Inactivated Vaccine (CoronaVac) is Independent to Vitamin D Levels [PDF]

Zeynep Şahiner, Arzu Okyar Baş, Merve Güner, Serdar Ceylan, Merve Hafızoğlu, Didem Karaduman, Cansu Atbaş, Burcu Balam Doğu, Mustafa Cankurtaran, Filiz Akbıyık, B. Çakır, Serhat Ünal, Meltem Halil   +12 more
openalex   +1 more source

COVID-19 breakthrough infections during the circulation of Delta and Omicron variants in Tirana, Albania, April 2021-March 2022. [PDF]

PLoS One
Konomi F, Bino S, Mersini K, Ramaj A, Danis K.   +4 more
europepmc   +1 more source

Gambaran Kejadian Ikutan Pasca Imunisasi (KIPI) Vaksin COVID-19 (Coronavac) Pada Tenaga Kesehatan Di Rumah Sakit Umum Daerah Syekh Yusuf Kabupaten Gowa

Nur Fadila, Nurul Ulfah Mutthalib, Nurfardiansyah Bur   +2 more
openalex   +2 more sources

Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccine. [PDF]

iScience
Martínez-Balboa Y, Rodríguez-Guilarte L, Méndez C, Ríos M, Rivera DB, Moreno-Tapia D, Reyes HA, Pereira-Sánchez P, Orellana C, Cabrera A, Schultz BM, Duarte LF, Gálvez NMS, Melo-González F, Soto JA, Iturriaga C, Urzúa M, Navarrete MS, Rojas Á, Fasce RA, Fernández J, Mora J, Ramírez E, Weiskopf D, Grifoni A, Sette A, Zeng G, Meng W, CoronaVac03CL Study Group, Alvarez-Figueroa MJ, González-Aramundiz JV, Domínguez MA, González PA, Abarca K, Peñaloza HF, Bueno SM, Kalergis AM.   +36 more
europepmc   +1 more source

Immunogenicity and safety of CoronaVac vaccine in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up. [PDF]

Sci Rep
Corsini CA, da Silva Martins PF, Filgueiras PS, Lourenço AJ, de Souza Lima AE, Gomes SVC, de Jesus Jeremias W, Alves PA, da Rocha Fernandes G, Castro LLME, Teixeira-Carvalho A, Azevedo ACC, De Almeida Leitao Curimbaba C, Lorencini DA, Junior EM, da Silva VM, Cervi MC, de Carvalho Borges M, Nogueira ML, Campos GRF, Correa PRL, Carvalho TML, Dos Reis JGAC, de Sousa Reis EV, Dos Reis Castilho L, de Lima PR, do Nascimento JPR, de Oliveira JG, Filho OAM, Immunita Team, Grenfell RFQE.   +30 more
europepmc   +1 more source

Neutralization and Anti-S Antibody Titers in SARS-CoV-2 Boosted Adults in Mexico: A Comparison Across Five Vaccine Types. [PDF]

Int J Microbiol
Blas N, Carnalla M, Basto-Abreu A, Martínez-Barnetche J, Alpuche-Aranda C, Gaspar-Castillo C, Aparicio-Antonio R, Dimas-González J, López I, Sánchez-Casiano NE, Barrientos-Gutiérrez T.   +10 more
europepmc   +1 more source

Which type of vaccine is more beneficial for reducing the risk of deep vein thrombosis, CoronaVac, BNT162b2, or TURKOVAC? [PDF]

Sci Prog
Yazıcı S, Beyazal OF, Tezcan H.
europepmc   +1 more source